HLA-E Presents Glycopeptides from the Mycobacterium tuberculosis Protein MPT32 to Human CD8+ T cells

Melanie J. Harriff,Lisa M. Wolfe,Gwendolyn Swarbrick,Megan Null,Meghan E. Cansler,Elizabeth T. Canfield,Todd Vogt,Katelynne Gardner Toren,Wei Li,Mary Jackson,Deborah A. Lewinsohn,Karen M. Dobos,David M. Lewinsohn
DOI: https://doi.org/10.1038/s41598-017-04894-0
IF: 4.6
2017-07-04
Scientific Reports
Abstract:Infection with Mycobacterium tuberculosis (Mtb), the bacterium that causes tuberculosis, remains a global health concern. Both classically and non-classically restricted cytotoxic CD8+ T cells are important to the control of Mtb infection. We and others have demonstrated that the non-classical MHC I molecule HLA-E can present pathogen-derived peptides to CD8+ T cells. In this manuscript, we identified the antigen recognized by an HLA-E-restricted CD8+ T cell clone isolated from an Mtb latently infected individual as a peptide from the Mtb protein, MPT32. Recognition by the CD8+ T cell clone required N-terminal O-linked mannosylation of MPT32 by a mannosyltransferase encoded by the Rv1002c gene. This is the first description of a post-translationally modified Mtb-derived protein antigen presented in the context of an HLA-E specific CD8+ T cell immune response. The identification of an immune response that targets a unique mycobacterial modification is novel and may have practical impact in the development of vaccines and diagnostics.
multidisciplinary sciences
What problem does this paper attempt to address?